Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
DIANEAL 137 with 1.5% dextrose is a peritoneal dialysis solution that removes waste products and excess fluid from the blood by creating a concentration gradient across the peritoneal membrane via diffusion and ultrafiltration. Dextrose acts as an osmotic agent to drive fluid removal.
Dianeal PD-1 with Dextrose 1.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create a concentration gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the peritoneal cavity via diffusion and ultrafiltration.
Intraperitoneal administration: 2 liters per exchange, typically 4 exchanges per day for continuous ambulatory peritoneal dialysis (CAPD).
2 L intraperitoneally via continuous ambulatory peritoneal dialysis (CAPD) four times daily, with dwell times of 4-6 hours each. For automated peritoneal dialysis (APD), 2 L per cycle with 4-5 cycles overnight.
None Documented
None Documented
Not applicable for dextrose as it is an endogenous substance. Exogenous dextrose in peritoneal dialysis is rapidly metabolized; plasma glucose half-life is approximately 1-2 hours after absorption, but this varies with metabolic state.
Dextrose half-life is approximately 1-2 hours in normal individuals; with peritoneal dialysis, elimination is governed by dialysate dwell time and peritoneal transport characteristics, typically 4-6 hours for complete absorption.
Dianeal 137 with 1.5% dextrose is a peritoneal dialysis solution. Dextrose is metabolized systemically; glucose is absorbed via peritoneal route and undergoes endogenous metabolism. Icodextrin (if applicable) is metabolized to maltose and excreted renally, but for this standard solution, elimination is primarily via metabolism to CO2 and water; less than 5% excreted unchanged in urine. No biliary or fecal elimination of intact dextrose.
Renal: dialysis (peritoneal) accounts for >95% of dextrose elimination; minimal renal excretion (<5% unchanged dextrose). Biliary/fecal: negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution